Oscar T. L.
- Country
- Spain
- Department
- Oncology
Research Overview
- Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
Data & Insights
Has run more than one trial at 11 of 138 partner sites.
Specializations
Breast Cancer & Endocrine Therapy
The investigator specializes in treating patients with hormone receptor-positive breast cancer, particularly focusing on managing side effects of adjuvant endocrine therapy.
- Stage 0-3 breast cancer management
- Hormone receptor-positive breast cancer treatment
- High-risk breast cancer prevention
Their work extends to preventive approaches for patients at elevated risk of developing breast cancer.
Vasomotor Symptoms Management
The investigator has developed expertise in treating moderate to severe vasomotor symptoms (VMS) that occur as a consequence of cancer treatments.
- Hot flash treatment
- Cancer therapy side effects
- Quality of life improvements
Their therapeutic focus includes innovative approaches to managing treatment-induced vasomotor symptoms.
Therapeutic Innovation
The investigator explores novel therapeutic compounds for managing endocrine therapy-related symptoms in cancer patients.
- Novel therapeutic agents
- Symptom management strategies
- Treatment optimization
Their work encompasses evaluating new medications for improving patient comfort during cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.